Items where Division is "Current Faculties > Faculty of Medicine > Centre for Cancer Immunology" and Year is 2025
 | Up a level |
Number of items: 12.
Type: Patent
| 2025
| Item not available on this server.
Quantitative imaging of loop extruders rebuilding interphase genome architecture after mitosis - Andreas Brunner, Natalia Rosalía Morero, Wanlu Zhang, M Julius Hossain, Marko Lampe, Hannah Pflaumer, Aliaksandr Halavatyi, Jan-Michael Peters, Kai S Beckwith and Jan Ellenberg
Type: Article
| 2025
| Item not available on this server.
CD27 agonist antibodies mediate clinical responses through intratumoral stimulation in B-cell malignancies: multicenter RiVa trial - Lara E. Buermann, Louise Stanton and Matthew J.J. Rose-Zerilli
Type: Article
| 2025
| Item availability restricted.
The ETS-family transcription factor PU.1 is a critical regulator of the inhibitory Fcγ receptor IIB expression in humans - Matthew J. Carter, Yury D. Bogdanov, Rosanna C. Smith, Kerry L. Cox, Sarah Frampton, Lili Ferson, Russell B. Foxall, Khiyam Hussain, Jonathan C. Strefford, Stephen A. Beers and Mark S. Cragg
Type: Article
| 2025
A First-in-Class mAb (BI-1607) Targeting FcγRIIB: preclinical data and first-in-human studies in patients with HER2-positive advanced solid tumors - Javier Cortés, Araceli Priego, Elena Garralda, Katerin Rojas, Simon R. Lord, Thorsten O. Goetze, Sherko Kuemmel, Simon J. Crabb, Zinnia P. Parra-Guillen, Marie Borggren, Ingrid Karlsson, Danijela Lindahl, Linda Mårtensson, Robert Oldham, Anna Ropenga, Ingrid Teige, Johan Wallin, Björn Frendeus and Andres McAllister
Type: Article
| 2025
Structure-guided disulfide engineering restricts antibody conformation to elicit TNFR agonism - Isabel G. Elliott, Hayden Fisher, H.T. Claude Chan, Tatyana Inzhelevskaya, C. Ian Mockridge, Christine A. Penfold, Patrick J. Duriez, Christian M. Orr, Julie Herniman, Kri T.J. Müller, Jonathan W. Essex, Mark S. Cragg and Ivo Tews
Type: Article
| 2025
Therapeutic targeting of tumour-associated macrophage receptors. - Rosa Gomes Alves Martins, Mehmet Masum Tekin, Mark Cragg and Ali Roghanian
Type: Review
| 2025
CD40L and IL-4 suppress NK cell-mediated antibody-dependent cellular cytotoxicity through the HLA-E:NKG2A axis - Lara V. Graham, Ludmila Horehajova, Marco V. Haselager, Jack G. Fisher, Jamie Lee Roos, Russell B. Foxall, Mel John, Kerry L. Cox, Robert J. Oldham, Martin C. Taylor, Margaret Ashton-Key, Ben Sale, Laura G. Bartlett, Ali Roghanian, Eric Eldering, Andres F. Vallejo, Francesco Forconi, Salim I. Khakoo, Mark S. Cragg and Matthew D. Blunt
Type: Article
| 2025
Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY study - Lisa Mumford, Rachel Hogg, Adam Taylor, Peter Lanyon, Mary Bythell, Sean McPhail, Joseph Chilcot, Gillian Powter, Graham S Cooke, Helen Ward, Helen Thomas, Stephen P. McAdoo, Liz Lightstone, Sean H. Lim, Gavin J. Pettigrew, Fiona A. Pearce and Michelle Willicombe
Type: Article
| 2025
FcγRIIB (CD32B) antibodies enhance immune responses through activating FcγRs - Alexander P. Simpson, Robert J. Oldham, Kerry L. Cox, Martin C. Taylor, Sonya James, Yury Bogdanov, Martin J. Glennie, Bjorn Frendeus, Mark S. Cragg and Ali Roghanian
Type: Article
| 2025
Intraoperative electron radiotherapy (IOERT) in colorectal cancer: updated systematic review of techniques, oncological outcomes and complications - Abhinav Tiwari, Sheah Lin Lee, Tom MacCabe, Michal Woyton, Charles T. West, Rohan Micklethwaite, Hideaki Yano, Malcolm A. West and Alex H. Mirnezami
Type: Review
| 2025
Harnessing Multivalency and FcγRIIB Engagement to Augment Anti-CD27 Immunotherapy - Marcus Widdess, Anastasia Pakidi, Hannah Metcalfe, Claude Chan, Tatyana Inzhelevskaya, Christine Penfold, Christopher I Mockridge, Steven Booth, Sonya James, Sean Lim, Stephen Beers, Mark Cragg and Aymen Al-Shamkhani
Type: Article
| 2025